Wordt geladen...

Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate

BACKGROUND: Studies suggest that patients with relapsing–remitting multiple sclerosis (RRMS) who fail to benefit from a disease-modifying treatment (DMT) may benefit from converting to another DMT class. COPTIMIZE was a 24-month observational study designed to assess the disease course of patients c...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Neurol
Hoofdauteurs: Ziemssen, Tjalf, Gilgun-Sherki, Yossi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2015
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599648/
https://ncbi.nlm.nih.gov/pubmed/26450155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-015-0448-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!